Clinical Trial Update: TERPS Trial for de Novo Oligometastic Prostate Cancer [Phase 2]

View source ↗

Summary

The TERPS Phase 2 trial for de novo oligometastatic prostate cancer is currently recruiting, sponsored by the University of Maryland, Baltimore.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Prostate Cancer, Oligometastatic Disease | Phase 2 | Status: RECRUITING